LLY vs PFE

Eli Lilly and Company vs Pfizer, Inc. · Healthcare · scored 2026-08-04

LLYEli Lilly and Company54 Gem
VSEdge pick: LLY — Eli Lilly and Companyhigher Gem Score
PFEPfizer, Inc.54 Gem

Head-to-head

The numbers that matter, side by side. A star marks the stronger stock on each merit measure.

MeasureLLYPFE
Gem Score54/100 ★54/100
Strategies agreeing5 ★4
Price$1,121.36$25.03
Market cap$1000B$143B
Market regimeBullishBearish
Best-fit thesisCAN SLIMLow-Vol Defensive
Win probability46% · 46%
Estimated edge+25.0% · +24.8%

Modeled from the GemStox stochastic + volatility models (order: LLY · PFE). Not financial advice.

Strategy-thesis head-to-head

GemStox scores each stock across 14 independent investment theses. Here is where they differ.

Strategy thesisLLYPFEΔ
Deep Value
11
44
★
-33
GARP
75
★
51
+25
Mean Reversion
36
46
★
-10
Quality Compounder
70
71
★
-1
CAN SLIM
83
★
17
+66
Low-Vol Defensive
40
88
★
-48
Catalyst / Event
41
★
31
+10
Dividend Growth
22
★
22
+1
S-Curve Growth
40
★
32
+8
Piotroski F-Score
67
78
★
-11
Operating Leverage
100
★
5
+95
Net Payout Yield
20
80
★
-60

LLY leads 6, PFE leads 6 — of 12 comparable theses

Dimension by dimension

Average sub-signal score across valuation, quality, risk, growth, and momentum.

DimensionLLYPFE
Valuation
32
50
★
Quality
58
★
53
Risk
41
78
★
Growth
62
★
28
Momentum & Technicals
38
★
27

How this comparison is computed

Every figure is computed from the same cached market + fundamentals data GemStox uses to score individual stocks — no two theses double-count. Try the free Stock Score calculator, read the full scoring methodology, or open either single-stock analysis above for the full 14-signal breakdown.

Free: compare any stocks in the live app →

Open the GemStox Compare tool and put any two (or up to ten) tickers head-to-head — live win probability, optimal position size, and pre-calculated stop/target levels. It's free to try: 3 comparisons a day, no account, then upgrade from $3 for unlimited.

Compare free in the app →

Educational comparison generated from cached market + fundamentals data as of 2026-08-04. Not investment advice. Past performance does not guarantee future results.